COVID-19 Generates $3.4 Billion in Pharma-Bio Industry Capital Projects, an Industrial Info Market Brief

The headlines are filled with news of billions of COVID-19 dollars being dispersed to build up capacity in the Pharma-Bio Industry. Virtually every sector of the industry that provides a product to cure, prevent and treat the insidious virus has been involved. Yet, not all of that money is being funneled into new capital expenditures, as much goes into development and planning.